Suchergebnisse - "Liu, Yalan"

PubPharm (8)

1

Dual block HER2 assessment increased HER2 immunohistochemistry positive rate in resected specimens of gastric cancer : a prospective multicenter clinical trial from China

enthalten in: Diagnostic pathology | 2022

von Xu, C. | Sun, M. | Jin, M. | +11

2

HER2 promotes epithelial-mesenchymal transition through regulating osteopontin in gastric cancer

enthalten in: Pathology, research and practice | 2021

von Liu, Y. | Chen, L. | Jiang, D. | +4

3

Late stage gastric cancer patients with extra gained HER2 positivity by dual block assessment may not show compromised efficacy to trastuzumab treatment

enthalten in: Aging | 2019

von Xu, C. | Liu, Y. | Jiang, D. | +9

4

HER2 assessment in locally advanced gastric cancer : comparing the results obtained with the use of two primary tumour blocks versus those obtained with the use of all primary tumour blocks

enthalten in: Histopathology | 2017

von Xu, C. | Liu, Y. | Jiang, D. | +12

5

Tumor containing fragment number influences immunohistochemistry positive rate of HER2 in biopsy specimens of gastric cancer

enthalten in: Diagnostic pathology | 2017

von Xu, C. | Liu, Y. | Ge, X. | +9

6

Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type

enthalten in: Oncotarget | 2017

von Xu, C. | Liu, Y. | Jiang, D. | +10

7

Heterogeneous Her2/Neu expression in gastric and gastroesophageal cancer-reply

enthalten in: Human pathology | 2016

von Ge, X. | Wang, H. | Xu, C. | +5

CommentOn: Hum Pathol. 2015 Jun;46(6):850-7. - PMID 25863425

8

Clinical significance of assessing Her2/neu expression in gastric cancer with dual tumor tissue paraffin blocks

enthalten in: Human pathology | 2015

von Ge, X. | Wang, H. | Zeng, H. | +12

CommentIn: Hum Pathol. 2016 Feb;48:173-4. - PMID 26688559

1
[1]